reagent grade. Controlled pore glass (aminopropyl CPG: mean pore size 53.8 nm; particle size 63 -125 µm; amine content 98.2 µmol g -1 ) was obtained from CPG Inc. (Fairfield, NJ), and was used as a support material for enzyme immobilization. The phosphate buffers used as a carrier solution were prepared from sodium dihydrogenphosphate. The Ringer's solution used as a perfusion medium was prepared from NaCl (147 mM), KCl (4 mM), CaCl2 (1.2 mM), and MgCl2 (1.0 mM). Distilled water purified using a Millipore Milli-Q system (Nippon Millipore, Tokyo) was used throughout.
Preparation of immobilized enzyme reactors and poly(1,2-diaminobenzene) film-coated platinum electrode
Aminopropyl CPG was packed into two PTFE tubes (10 mm × 1.5 mm i.d.) furnished with small nylon nets (350 mesh) at the ends, and a 4% (v/v) glutaraldehyde solution in 0.1 mM sodium hydrogen carbonate was pumped for 1 h to activate the support. After washing with distilled water, each of the enzymes (GOD and LOD) was loaded onto each reactor by pumping a 0.1 M, pH 6.5, sodium phosphate buffer (500 µl) containing GOD (210 U) or LOD (40 U). The excess of enzymes and the residual aldehyde groups on the CPG were removed by washing with glycine buffer (0.1 M, pH 7.5) for 2 h. The reactors were stored at 5˚C in a 0.1 M sodium phosphate buffer (pH 7.0) when not in use.
An Eicom (Kyoto) thin-layer electrochemical flow-cell was used for a surface modification of the electrode. The electrode assembly consisted of a platinum disk (3 mm in diameter) as a working electrode, a silver-silver chloride reference electrode, and a stainless-steel tube as an auxiliary electrode. The poly(1,2-diaminobenzene) film-coated platinum electrode was prepared by the electropolymerization of 1,2-diaminobenzene, according to previously described procedures. 20, 21 It was also stored in a 0.1 M sodium phosphate buffer (pH 7.0) when not in use.
Microdialysis FIA system
The microdialysis FIA system used in this work is outlined in Fig. 1 . A flow-through microdialysis probe was a gift from Eicom (BDP-I-8-03). The design was almost identical to that described before. 18 A two-channel microsyringe pump (Eicom EP-60) was used for the delivery of perfusate (Ringer's solution). A microdialysis probe was connected to one port of a six-way autoinjector (Eicom EAS-20) with a 50-cm length of microline tubing (0.1 mm i.d.). The FIA set up was made up of an Eicom GASTORR, an Eicom double plunger µl pump, an injector (Rheodyne 7125) with a sample loop of 5 µl, a six-way autoinjector with a sample loop of 2.5 µl, two enzyme reactors positioned as shown, and an electrochemical detector (Eicom ECD-300) with a potentiostat and a flow-cell. A constant potential (+0.6 V vs. Ag/AgCl) was applied to the poly(1,2-diaminobenzene) film-coated platinum electrode and the current was recorded on a Yanagimoto R3-201 strip-chart recorder.
Procedures and analytical principle
A microdialysis probe was immersed in a sample solution containing glucose and L-lactate for an in vitro assay and implanted into the frontal lobe of rat brain according to the conventional procedures 23 for an in vivo assay. In the first stage (load mode in Fig. 1 ; for 80 s) of the operation, the dialysate from the probe was delivered to the sample loop of a six-way autoinjector by perfusing Ringer's solution at a flow rate of 5 µl min -1 . Simultaneously, a standard solution containing glucose and L-lactate (0.1 mM each) was occasionally injected in the FIA line for checking drifts in the sensitivity. The optimized carrier buffer was a 0.1 M, pH 7.0, sodium phosphate buffer containing 147 mM NaCl and pumped at 0.5 ml min -1 . In the second stage (injection mode in Fig. 1; for 10 s) , the dialysate collected in the sample loop was injected into the carrier stream by switching the valve. The injected dialysate was split into two sub-zones at the T-connector, and two portions were passed through enzyme reactors inserted in the flow lines with different dimensions, to produce enzymatically hydrogen peroxide. The produced hydrogen peroxide could be amperometrically detected by a downstream poly(1,2-diaminobenzene) filmcoated platinum electrode after a subsequent confluence of the streams. Switching of the valve was repeated automatically at a regular time interval. A delay coil (DC) was also inserted in the flow line, as shown. Because of the different residence times of two sample portions to reach the detector, two peaks were obtained. The first peak corresponded to L-lactate and the second to glucose. The separation of the two peaks depended on the length of the delay coil; a delay PTFE coil, 290 cm × 0.5 mm i. 
Results and Discussion

Permselectivity of the poly(1,2-diaminobenzene) film-coated platinum electrode
In a preliminary in vivo experiment, a bare platinum electrode without any surface modification gave a response (approximately 100 nA) due to the electroactive interferences (probably L-ascorbate, urate, L-cysteine, etc.) present in dialysate, when the measurement was done using the microdialysis FIA system without any enzyme reactors. However, when the poly(1,2-diaminobenzene) film-coated platinum electrode was used as an amperometric detector, signals for the dialysate were decreased to negligibly small values (< 1.8 nA), as compared with that of the bare electrode. This means that a poly(1,2-diaminobenzene) film-coated platinum electrode prevented the electroactive interferences (Lascorbate etc.) from reaching the electrode surface and from interfering with the detection of hydrogen peroxide generated in the enzyme reactors. Actually, this polymer-coated electrode effectively excluded the L-ascorbate, urate, and L-cysteine below 2 mM, though the response current of the electrode for hydrogen peroxide was decreased to 56% of its previous value. Also, this electrode kept its desired properties for repetitive use over a period of 1 month. Such a permselectivity of the polymer-coated electrode is based on a size-exclusion effect by poly(1,2-diaminobenzeme) film coated on the electrode surface, as reported before. 24 Therefore, this polymer-coated electrode was used throughout in this work as an amperometric detector of hydrogen peroxide generated in the enzyme reactors.
Optimization of in vivo microdialysis FIA system
In the FIA system shown in Fig. 1 , Ringer's solution was pumped to the sample loop of a six-way autoinjector through a dialysis probe with a microsyringe pump, while the carrier solution was also pumped with a double plunger µl pump. The sodium phosphate buffer (0.1 M) at various pH values was tested as the carrier solution; the maximum response was obtained over a wide pH range of 5.5 -8.5 for each of glucose and L-lactate injections. However, at pH values above 7.8, phosphate ion in the buffer reacted to produce insoluble calcium phosphate with calcium ion in Ringer's solution; this was responsible for closing of the PTFE coil. Therefore, a 0.1 M sodium phosphate buffer at pH 7.0 was selected as the optimum carrier. Furthermore, 147 mM NaCl was added to the carrier buffer to adjust the ion strength, because the dialysate from the probe was Ringer's solution containing a high concentration of salts.
When the carrier flow rate was increased from 0.1 to 0.9 ml min -1 , while keeping the flow rate of the Ringer's solution constant at 5 µl min -1 and the sampling time by the dialysis probe of 80 s, respectively, the signal currents to glucose and Llactate gradually decreased, because the carrier flow rate was related to the residence time of the sample zone in the reactors. The time required for the simultaneous assay of glucose and Llactate, however, became excessive at lower flow rates, and so a flow rate of 0.5 ml min -1 was recommended. At this carrier flow-rate, the conversion efficiencies of L-lactate and glucose to hydrogen peroxide were 82% and 56%, respectively. Also, when the flow rate of the Ringer's solution was 5 µl min -1 , permeability into the probe was 5.9% for glucose and 8.3% for L-lactate, respectively. At higher flow rates of a perfusion solution, the permeabilities of glucose and L-lactate into the probe decreased remarkably. Therefore, this flow rate was selected in this work. Under these flow conditions, the optimum time intervals of the load and injection (see Fig. 1 ) were 80 and 10 s, respectively.
The microdialysis probe was immersed into a solution containing 1 mM each of glucose and L-lactate, and Ringer's solution and the carrier buffer were pumped at flow rates of 5 and 500 µl min -1 , respectively. The sample solution injected into the FIA flow line by valve switching, was split into two streams at a T-connector, and the two portions passed through two channels with a GOD or LOD immobilized reactor, with subsequent confluence of the streams before reaching the poly(1,2-diaminobenzene) film-coated platinum electrode. Each of glucose and L-lactate in sample solution was converted to hydrogen peroxide by an enzymatic reaction occuring in each channel. Two peaks were obtained for a mixture of glucose and L-lactate as shown in Fig. 2 , because each channel had a different residence time. The first peak corresponded to Llactate and the second to glucose, as shown in Fig. 2 . However, the separation of two peaks depended on the relative length or dimension of the channels; a delay PTFE coil, 290 cm × 0.5 mm i.d., was needed to separate the two peaks completely. Under these flow conditions, the analytical speed was 45 dialysates h -1 .
Calibration graphs for both species were run using standard solutions of glucose and L-lactate with concentrations between 0.05 and 50 mM, which were measured in triplicate under the recommended flow conditions. Figure 3 shows log-log calibration graphs for both species obtained by the present microdialysis sampling. The linear relation between the signal currents and each species was observed in the range of 0.2 -10 mM for L-lactate and 0.1 -20 mM for glucose, with linear correlation coefficients larger than 0.998. The upper limit was probably restricted because of an oxygen limitation in the carrier solution, while the lower limit was restricted because of a fluctuation of the base-line. The relative standard deviations of the signal currents for seven replicate measurements were 1.2% for 1 mM L-lactate and 1.8% for 1 mM glucose.
Also, the two enzyme reactors were used repeatedly to confirm their stabilities; even after repetitive use (ca. 10 samples per day) for two months, each reactor gave over 90% of the original signal for each substrate.
In vitro and in vivo monitoring
The proposed microdialysis FIA system was applied to a simultaneous assay of glucose and L-lactate in serum. The human control serum diluted with the Ringer's solution by a factor of three was repeatedly assayed. The analytical results obtained by using the calibration graphs for both species gave a negligible amount for L-lactate and 1.72 mM ± 0.04 mM for glucose; these results agreed closely with the manufacture's data, as shown in Table 1 . The relative standard deviation for five replicate assays was 2.3%. Also, the signal currents for glucose and L-lactate were monitored continuously for 3 h after a microdialysis probe was immersed in a same serum sample. The stability of the signal current for glucose in serum was fairly good; even after 3 h, the signal current for glucose retained 95% of its original current. Recovery studies were also carried out by adding known amounts of L-lactate and glucose to the serum sample diluted by a factor of three. The results showed good recoveries, ranging from 98 to 103% for both species (see Table 1 ).
In vivo monitoring of glucose and L-lactate in the rat brain was conducted by using the microdialysis FIA system shown in Fig. 1 and implanting a microdialysis probe into the frontal lobe of the rat. The rat was allowed to recover overnight in a large plastic box with free access to food and water. After the probe was connected to a microsyringe pump through a swivel to allow the rat free movement, glucose and L-lactate in the extracellular space of rat brain were monitored simultaneously over a period of 5 h. A part of FIA signals obtained is shown in Fig. 4 , and the time-courses of L-lactate and glucose concentrations are shown in Fig. 5 . The average amounts of Llactate and glucose in rat brain were about 0.6 -0.8 mM and 2 -2.5 mM, respectively, although their concentrations varied much less with the elapse of time. When a 1 ml aliquot of 1.67 M glucose was injected into the abdomen of the rat, the signal current of glucose increased up to a current corresponding to 3.5 mM, and then after 30 min it decreased up to the value before glucose injection, as shown in Fig. 5 . Furthermore, after 45 min a 1 ml aliquot of 3.33 M glucose was injected similarly into abdomen of the same rat, but the glucose concentration in rat brain was not increased beyond 3.5 mM. This means the presence of a "blood brain barrier" system, [25] [26] [27] which is one of the physiological protection systems of the brain. However, the L-lactate concentrations, although they increased much less when the rat was in motion, was not influenced by glucose injections, and kept almost constant during all periods of the measurement.
It was found from these results that the present microdialysis FIA system is useful for the in vivo monitoring of L-lactate and glucose in the extracellular space of rat brain. Furthermore, this method can be expected to be applied to the in vivo monitoring of glucose and L-lactate at other parts of the living cells, such as blood stream, subcutaneous tissue, and muscle. Table 1 Precision and recovery studies for the simultaneous determination of glucose and L-lactate in serum a by the present microdialysis FIA system a. The control serum diluted with Ringer's solution by a factor of three was used for both the simultaneous assay and recovery experiments of L-lactate and glucose (n = 5). b. Manufacturers data: no detectable amount for L-lactate and 1.68 ± 0.05 mM for glucose, respectively (n.d.: not detected). 
